There are concerns about a UK-US NHS drug deal, with some groups urging it be scrapped due to potential harm. The deal may affect access to a costly drug, potentially impacting multiple sclerosis patients. The situation is uncertain, with various health-related issues being reported, including NHS strikes and controversies over other health policies.